BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 28946909)

  • 1. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Liu Y; Latifi K; Stringfield O; Garcia A; Moros EG; Dilling TJ; Schabath MB; Ye Z; Gillies RJ
    Med Phys; 2017 Aug; 44(8):4341-4349. PubMed ID: 28464316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Peulen H; Mantel F; Guckenberger M; Belderbos J; Werner-Wasik M; Hope A; Giuliani M; Grills I; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):134-41. PubMed ID: 27325481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
    PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
    Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
    Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response criteria in solid tumors (PERCIST/RECIST) and SUV
    Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
    Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
    van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
    Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
    Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.
    Atallah S; Cho BC; Allibhai Z; Taremi M; Giuliani M; Le LW; Brade A; Sun A; Bezjak A; Hope AJ
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):532-8. PubMed ID: 24929163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
    Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience.
    Hasan S; Colonias A; Mickus T; VanDeusen M; Wegner RE
    Thorac Cancer; 2018 Jun; 9(6):699-706. PubMed ID: 29697204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer.
    Kohutek ZA; Wu AJ; Zhang Z; Foster A; Din SU; Yorke ED; Downey R; Rosenzweig KE; Weber WA; Rimner A
    Lung Cancer; 2015 Aug; 89(2):115-20. PubMed ID: 26078260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy.
    Oikonomou A; Khalvati F; Tyrrell PN; Haider MA; Tarique U; Jimenez-Juan L; Tjong MC; Poon I; Eilaghi A; Ehrlich L; Cheung P
    Sci Rep; 2018 Mar; 8(1):4003. PubMed ID: 29507399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
    Hoopes DJ; Tann M; Fletcher JW; Forquer JA; Lin PF; Lo SS; Timmerman RD; McGarry RC
    Lung Cancer; 2007 May; 56(2):229-34. PubMed ID: 17353064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
    Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
    Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
    Moran A; Daly ME; Yip SSF; Yamamoto T
    Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Semiautomatic CT Volumetry in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Satoh Y; Motosugi U; Nambu A; Saito A; Onishi H
    J Comput Assist Tomogr; 2016; 40(3):343-50. PubMed ID: 26854414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
    Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
    Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.